• Profile
Close

Progranulin is a novel biomarker for predicting an acute exacerbation of chronic obstructive pulmonary disease

The Clinical Respiratory Journal Aug 16, 2018

Chen X, et al. - Researchers assessed progranulin, a pleiotropic glycosylated protein precursor that plays an important role in inflammation, as a circulating biomarker of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Participants were patients with AECOPD (n = 52), patients with stable COPD (n = 56) and healthy controls (n = 36). Higher plasma progranulin levels were observed in patients with AECOPD vs both stable COPD patients and healthy controls. Patients with AECOPD had significantly decreased plasma progranulin levels on the last day of hospitalization vs those on the first day of hospitalization. In multivariate logistic regression and ROC analysis, progranulin was identified as an independent predictor of AECOPD, with an area under the curve of 0.82. Overall, they concluded progranulin to be a possible valuable blood biomarker of AECOPD and to be implicated in the pathogenesis of AECOPD by disturbing inflammatory responses.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay